Axogen, Inc. — Director's Dealing 2011

Nov 23, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AxoGen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2011-11-21

Reporting Person: Freitag Gregory Gene (Director, CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-11-21	Common Stock	P	500	$2.86	Acquired	500	Direct
2011-11-21	Common Stock	P	2500	$2.93	Acquired	3000	Direct
2011-11-21	Common Stock	P	3000	$2.88	Acquired	6000	Direct
2011-11-22	Common Stock	P	3000	$2.87	Acquired	9000	Direct
2011-11-22	Common Stock	P	6000	$2.94	Acquired	15000	Direct

Footnotes

F1: These shares were purchased in the open market